Showing results (151-160 of 260) with videos related to

Sort By:
Pageof 26
Cancer Immunology, Immunotherapy : CII|August 13, 2016
Identification of a naturally processed HLA-A*02:01-restricted CTL epitope from the human tumor-associated antigen Nectin-4Marc Lopez, Abderrezak Ghidouche, Caroline Rochas, et al.
The Journal of Experimental Medicine|May 5, 2017
Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cellsZakia Djaoud, Lisbeth A Guethlein, Amir Horowitz, et al.
Human Immunology|October 4, 2008
Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cellsDaniela Fenoglio, Francesca Ferrera, Marco Fravega, et al.
Cells|July 14, 2023
Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T CellsAnne-Charlotte Le Floch, Marie-Sarah Rouvière, Nassim Salem, et al.
European Journal of Immunology|April 8, 2017
Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activationLisa Starick, Felipe Riano, Mohindar M Karunakaran, et al.
Plos Pathogens|August 22, 2009
CpG methylation controls reactivation of HIV from latencyJana Blazkova, Katerina Trejbalova, Françoise Gondois-Rey, et al.
Cancers|June 2, 2021
Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling DonorRaynier Devillier, Boris Calmels, Sophie Guia, et al.
BMC Cancer|May 2, 2023
A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol studyGwenaelle Gravis, Patricia Marino, Daniel Olive, et al.
Frontiers in Immunology|August 27, 2019
Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to TherapiesAlessandra Marrella, Alessandra Dondero, Maurizio Aiello, et al.
Blood|May 3, 2002
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemiaRégis T Costello, Simona Sivori, Emanuela Marcenaro, et al.
Pageof 26